BioSpace News Archive

Biotech Beach

SeaSpine Announces Full Commercial Launch of the Admiral™ ACP System

SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of its Admiral ACP System.

November 23, 2021
·
4 min read
Biotech Beach

Puma Biotechnology Announces U.S Patent Term Extension for NERLYNX® (neratinib)

Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced that the United States Patent and Trademark Office (USPTO) issued a Patent Term Extension Certificate for U.S. Patent No. 7,399,865, extending the patent term five (5) years.

November 23, 2021
·
5 min read
Biotech Beach

Tarsus to Participate at Upcoming Virtual Investor Conferences - Nov 23, 2021

Tarsus Pharmaceuticals, Inc., whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, announced that management will participate in the following virtual investor conferences.

November 23, 2021
·
1 min read
Business

Rakovina Therapeutics Inc. Announces Third Quarter 2021 Financial Results and Provides Corporate Update

Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies today announced the financial results for its fiscal third quarter ending September 30, 2021 and provided a corporate update.

November 23, 2021
·
6 min read
FDA

Takeda’s LIVTENCITYTM (maribavir) Approved by U.S. FDA as the First and Only Treatment for People Ages 12 and Older with Post-Transplant Cytomegalovirus (CMV), Refractory (With or Without Genotypic Resistance) to Conventional Antiviral Therapies

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA) has approved LIVTENCITY™.

November 23, 2021
·
19 min read
Business

Operational Highlights and Financial Results for the Period Ended September 30, 2021

Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, reported operational highlights and financial results for the first quarter ended September 30, 2021.

November 23, 2021
·
19 min read
Mineral Trioxide Aggregate Market: The perforation repair segment held the largest market share

Mineral trioxide aggregate (MTA) is a dental material with biocompatibility properties to oral and dental tissues.

November 23, 2021
·
4 min read
Healthcare Descriptive Analysis Market: Competition Landscape and Key Developments

The potential of Big Data in healthcare and medical industries is multifaceted and incredible. A number of tools, methodologies, and information systems have been harnessed to explore that potential, increasingly for improving patient experience.

November 23, 2021
·
6 min read
Cold Plasma Equipment Market: The atmospheric cold plasma segment accounted for major share of the market

Cold plasma is ionized gas at room temperature that is produced by electric discharge. Cold plasma treatment is a contact-free and painless procedure to sterilize wounds and promote wound healing.

November 23, 2021
·
4 min read
Clostridium Vaccine (Animal Health) Market Report Detailed Analysis with Accurate Forecast to 2024

Clostridium vaccine is delivered in animals to fight against the clostridium family of pathogens/bacteria.

November 23, 2021
·
6 min read